GGrantIndex
Sort

82,697 grants matching vaccine development

Monitoring the development of anti-Env Abs during HIV infection

$694,153
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI

Monitoring the development of anti-Env Abs during HIV infection

$694,153
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AI

Development of Novel Antiviral Agents VS West Nile Virus

$694,081
Washington University · U01 · FY2005 · AI

Nanovaccine-Mediated Immune Protection Against Influenza Virus

$694,037
Kevin L Legge · University Of Iowa · R01 · FY2020 · AI

Expanded Phase II Trial of Carraguard for Prevention of HPV Infection

$693,999
Mark H. Einstein · Albert Einstein College Of Medicine · R01 · FY2014 · CA

Synergistic effects of HIV and age on naive CD4+ T-cell senescence

$693,992
Beth D. Jamieson-Karavodin · University Of California Los Angeles · R01 · FY2011 · AG

Development of a Novel, Sensitive ZIKV-Specific Sero-diagnostic Assay Utilizing Biologically Inspired Synthetic Molecules

$693,991
Donald S. Burke · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI

Gene Transfer and Somatic Cell Engineering Core

$693,977
Isabelle Riviere · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Investigating the role of maternal-fetal crosstalk on neonatal immunity in COVID-19 infection or vaccination in pregnancy

$693,928
Stephanie Lina Gaw · University Of California, San Francisco · R01 · FY2025 · HD

Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities

$693,828
Charles T Roberts · Oregon Health & Science University · R01 · FY2023 · DK

Antibody mediated immunity against Klebsiella pneumoniae

$693,822
Jason B Harris · Massachusetts General Hospital · R01 · FY2025 · AI

Discovering the Role of Commensal Microbes on Primary B Lymphocyte Development

$693,674
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2019 · AI

Discovering the Role of Commensal Microbes on Primary B Lymphocyte Development

$693,674
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2018 · AI

Discovering the Role of Commensal Microbes on Primary B Lymphocyte Development

$693,674
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2016 · AI

Discovering the Role of Commensal Microbes on Primary B Lymphocyte Development

$693,674
Duane R. Wesemann · Brigham And Women'S Hospital · R01 · FY2017 · AI

SERCEB Individual Career Development Support Program

$693,628
Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2011 · AI

Vaccines that Replicate the Neutralization-Competent Structure of the gp41 MPER

$693,593
Jamie K Scott · Simon Fraser University · R01 · FY2015 · AI

SIV Transmission in Male NHP

$693,573
Christopher Miller · University Of California At Davis · R01 · FY2015 · AI

Improvements to Biopharmaceutical Manufacturing

$693,541
Susan T Sharfstein · Hocuslocus, Inc. · R42 · FY2018 · GM

Mapping infant and adult T cell immunity

$693,465
Brian David Rudd · Cornell University · R37 · FY2025 · AI

Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy

$693,376
Jennifer R Grandis · University Of California, San Francisco · R35 · FY2018 · CA

Immune Responses to Vaccinia Virus Vaccination

$693,340
Jeffrey Cohen · Niaid Extramural Activities · Z01 · FY2007 · AI

Discovery of long-acting, chemoprotective antimalarial compounds

$693,310
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2023 · AI

Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine

$693,310
Joana Carneiro Da Silva · University Of Maryland Baltimore · R01 · FY2022 · AI

Adoptive transfer of immunity elicited by attenuated HIV vaccines

$693,305
David H Oconnor · University Of Wisconsin-Madison · R01 · FY2011 · AI